By Saadia Aslam Major bleeding that requires hospitalisation occurs in 2% to 3.5% of patients that take DOACs. Some of these patients may require reversal…
View More Reversal agents for DOACs – a recent meta-analysis
Tag: JACC
Greater adverse outcomes in patients presenting with COVID-19 and STEMI
Outcomes from the North American COVID-19 STEMI registry The goal of the NACMI (North American COVID-19 and STEMI) registry is to describe demographic characteristics, management…
View More Greater adverse outcomes in patients presenting with COVID-19 and STEMI